Altre lingue Star Combo Pharma Limited

Azioni

S66

AU0000004798

Mercato chiuso - Australian S.E. Altri mercati azionari 06:20:15 17/06/2024			Variaz. 5gg	Var. 1 gen.
0,11 ^AUD	+4,76%		0,00%	-24,14%

27/02	Star Combo Pharma Limited riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI
2023	Star Combo Pharma Limited riporta i risultati degli utili per l'intero anno terminato il 30 giugno 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/08/23
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2022	26/02/23
An unknown buyer acquired 49% stake in Austoyou Group Pty Ltd and Koala Mall Pty Ltd from Star Combo Pharma Limited.	24/02/23
Star Combo Pharma Limited Announces Resignation of Ziye Sui as Non- Executive Director	30/08/22
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2022	23/08/22
Star Combo Pharma Issues Shares to Vietnamese Distributor	05/07/22
Star Combo Pharma : S66 Dec 2021 Half Year Report and Financial Statements	23/02/22
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2021	23/02/22
Star Combo Pharma Limited Announces Group Revenue Results for the Second Quarter Ended 31 December 2021	30/01/22
Star Combo Pharma : S66 - CEO Presentation to 2021 AGM	23/11/21
Star Combo Pharma Limited Announces Supplementary Announcement on New Contract	08/11/21
Australian Shares Extend Gains as IT, Financial Counters Offset Losses in Energy	04/11/21
Star Combo Pharma Secures Nearly $4 Million Order for Bulk Capsules	04/11/21
Star Combo Pharma Limited Receives $5.0 Million Order	03/11/21
Star Combo Pharma : Signs Deal for Health Supplement Distribution to Vietnam	11/10/21
Star Combo Signs 12-Month Exclusive Distribution Agreement with Happy Co. Ltd for Widespread Sales and Distribution of its Proprietary Health Supplement Product Line, Costar Across Vietnam	10/10/21
Star Combo Pharma : Secures Approval for New Research and Development Facility	06/09/21
Star Combo Pharma Limited Announces Development Application Approval Receives for R&D Facilities At Smithfield	06/09/21
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2020	23/02/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Star Combo Pharma Limited

Azioni

S66

AU0000004798

Altre lingue

Filtri